Skip to content

Pharmacokinetic study of colistimethate sodium

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520019-41-00
Enrollment
56
Registered
2025-04-24
Start date
2025-06-30
Completion date
2025-07-20
Last updated
2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

serious infections caused by selected aerobic gram-negative pathogens in patients with limited treatment options

Interventions

None listed

Sponsors

Tarchominskie Zaklady Farmaceutyczne Polfa S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026